Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Debaryomyces hansenii is a non-pathogenic yeast that has seen some scientific interest for its potential probiotic effects, particularly within the gastrointestinal tract, including the small intestine. Research has shown that certain strains of D. hansenii can survive passage through the upper digestive tract, adhere to intestinal mucosa, and may help modulate gut microbiota. Experimental studies in animal models (such as mice and fish) have indicated that supplementation with D. hansenii can influence immune responses, improve gut barrier function, and possibly reduce colonization by pathogenic bacteria.

However, direct evidence supporting its specific use for supporting human small intestine health is still limited. Most of the available studies are preclinical, and there are few, if any, well-controlled human trials assessing its efficacy for small intestinal health or related conditions. The yeast has been used in animal feed, particularly in aquaculture, where it supports gut health and immune function, but extrapolation to human health requires caution. The possible mechanisms by which D. hansenii could benefit the small intestine include competitive exclusion of pathogens, production of antimicrobial substances, and modulation of the host immune system.

In summary, there is some emerging scientific evidence—primarily from in vitro and animal studies—that Debaryomyces hansenii may offer benefits to the small intestine, but human evidence remains weak. Therefore, its use for this body system is rated as modestly supported by scientific research.

More about Debaryomyces hansenii
More about Small Intestines

Other ingredients that support Small Intestines

Other body systems supported by Debaryomyces hansenii

Products containing Debaryomyces hansenii